Loading…
Company strengthens intellectual property portfolio.
ProPhase Labs, Inc. (OTC: PRPH) announced on August 12, 2025, that it has been granted a new patent. The patent issuance enhances the company's intellectual property portfolio, providing additional protection for its innovative products and technologies.
The newly granted patent is a significant addition to ProPhase Labs' existing patents, reinforcing its competitive position in the medical and pharmaceutical industry. With a free float of 42,845,800 shares and 46,179,000 shares outstanding, the company continues to focus on expanding its intellectual property assets.
This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.